|

Placebo matching Dapaglifolzin Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • University Hospital Tuebingen1

Indications

  • Type2diabetes1
  • PreDiabetes1
  • Renal Failure1
  • Diabetes1

Other1 trial

SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.